02-6410. National Cancer Institute; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Institute Board of Scientific Advisors.

    The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended to disclose information of a personal nature where disclosure would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Board of Scientific Advisors.

    Date: March 25, 2002.

    Open: March 25, 2002, 8:30 a.m. to 10:30 a.m..

    Agenda: Joint meeting of the NCI Board of Scientific Advisors and NCI Board of Scientific Counselors; Report of the Director, NCI; and Scientific Presentations.

    Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6 Floor, Conference Room 10, Bethesda, MD 20892.

    Open: March 25, 2002, 10:30 AM to 5:00 PM.

    Agenda: Ongoing and New Business; Reports of Program Review Group(s); and Budget Presentation; Reports of Special Initiatives; RFA and RFP Concept Reviews; and Scientific Presentations.

    Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6 Floor, Conference Room 10, Bethesda, MD 20892.

    Closed: March 25, 2002, 5 p.m. to 6 p.m.

    Agenda: To review and evaluate personnel issues.

    Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6 Floor, Conference Room 10, Bethesda, MD 20892.

    Contact Person: Paulette S. Gray, PhD, Executive Secretary, Deputy Director, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8141, Bethesda, MD 20892, (301) 496-4218.

    In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and sign-in at the security desk upon entering the building.

    Information is also available on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda and any additional information for the meeting will be posted when available.

    This notice is being published less than 15 days prior to the meeting date due to scheduling conflicts.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: March 12, 2002.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 02-6410 Filed 3-15-02; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
3/25/2002
Published:
03/18/2002
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
02-6410
Dates:
March 25, 2002.
Pages:
12026-12026 (1 pages)
PDF File:
02-6410.pdf